Du-xian X. Liu

Nanjing Key Laboratory Of Hepatology
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' Reply.

Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 05, 2026

Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis? Authors' Reply.

Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis? Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 05, 2026

Letter: The association between liver biochemistry, biliary and fibrosis in primary biliary cholangitis.

Letter: The association between liver biochemistry, biliary and fibrosis in primary biliary cholangitis.

Journal: Alimentary pharmacology & therapeutics

Published: February 01, 2026

Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.

Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.

Journal: Alimentary pharmacology & therapeutics

Published: November 20, 2025

Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis.

Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis.

Journal: BMC gastroenterology

Published: April 16, 2025

Optimizing phage therapy for carbapenem-resistant Enterobacter cloacae bacteremia: insights into dose and timing.

Optimizing phage therapy for carbapenem-resistant Enterobacter cloacae bacteremia: insights into dose and timing.

Journal: Antimicrobial agents and chemotherapy

Published: February 26, 2025

Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model.

Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model.

Journal: The Journal of antimicrobial chemotherapy

Published: January 13, 2025

Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson's Disease Hepatic Type.

Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson's Disease Hepatic Type.

Journal: Journal of clinical and translational hepatology

Published: December 02, 2024

Etiologies of Persistent Aminotransferase Elevations in Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogs.

Etiologies of Persistent Aminotransferase Elevations in Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogs.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: August 05, 2024

HVPG minimally invasive era: exploration based on forearm venous approach

HVPG minimally invasive era: exploration based on forearm venous approach

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: February 06, 2024

Precirrhotic Primary Biliary Cholangitis with Portal Hypertension: Bile Duct Injury Correlate.

Precirrhotic Primary Biliary Cholangitis with Portal Hypertension: Bile Duct Injury Correlate.

Journal: Gut and liver

Published: November 13, 2023

Liver biopsy-proven non-alcoholic fatty liver disease predicts no impact on antiviral response in patients with chronic hepatitis B.

Liver biopsy-proven non-alcoholic fatty liver disease predicts no impact on antiviral response in patients with chronic hepatitis B.

Journal: Clinics (Sao Paulo, Brazil)

Published: November 10, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026